Table 3.
Overall survival | ||||
---|---|---|---|---|
Univariate analysis | Multivariate analysis | |||
HR (95% CI) | p Value | HR (95% CI) | p Value | |
Age (yr) | 0.895 (0.530–1.512) | 0.679 | ||
Gender | 1.222 (0.723–2.066) | 0.455 | ||
Tumor location | 1.168 (1.000–1.364) | 0.050* | 1.190 (0.994–1.423) | 0.058 |
T classification | 3.182 (1.705–5.937) | < 0.001* | 2.938 (1.404–6.149) | 0.004* |
N classification | 2.243 (1.615–3.115) | < 0.001* | 0.912 (0.586–1.419) | 0.002* |
M classification | 9.412 (5.481–16.162) | < 0.001* | 9.385 (4.907–17.952) | < 0.001* |
AJCC stage (III -IV vs I- II) | 7.927 (3.394–18.511) | < 0.001* | 3.369 (1.147–9.895) | 0.027* |
Recurrence | 3.730 (2.144–6.488) | < 0.001* | 5.667 (2.882–11.140) | < 0.001* |
Differentiation | 0.616 (0.370–1.025) | 0.062 | ||
AGGF1 | 4.182 (2.384–7.333) | < 0.001* | 3.320 (1.814–6.077) | < 0.001* |
HR: hazard ratio; CI: confidence interval
* Significant differences